Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase - PubMed (original) (raw)

Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase

S Moriya et al. Proc Natl Acad Sci U S A. 1996.

Abstract

Protein kinase C (PKC), a major cellular receptor for tumor-promoting phorbol esters and diacylglycerols (DGs), appears to be involved in a variety of cellular functions, although its activation mechanism in vivo is not yet fully understood. To evaluate the signaling pathways involved in the activation of PKC epsilon upon stimulation by platelet-derived growth factor (PDGF) receptor (PDGFR), we used a series of PDGFR "add-back" mutants. Activation of a PDGFR mutant (Y40/51) that binds and activates phosphatidylinositol 3-kinase (PI 3-kinase) caused translocation of PKC epsilon from the cytosol to the membrane in response to PDGF. A PDGFR mutant (Y1021) that binds and activates phospholipase C gamma (PLC gamma), but not PI 3-kinase, also caused the PDGF-dependent translocation of PKC epsilon. The translocation of PKC epsilon upon stimulation of PDGFR (Y40/51) was inhibited by wortmannin, an inhibitor of PI 3-kinase. Activation of PKC epsilon was further confirmed in terms of PKC epsilon-dependent expression of a phorbol 12-tetradecanoate 13-acetate response element (TRE)-luciferase reporter. Further, purified PKC epsilon was activated in vitro by either DG or synthetic phosphatidylinositol 3,4,5-trisphosphate. These results clearly demonstrate that PKC epsilon is activated through redundant and independent signaling pathways which most likely involve PLC gamma or PI 3-kinase in vivo and that PKC epsilon is one of the downstream mediators of PI 3-kinase whose downstream targets remain to be identified.

PubMed Disclaimer

Cited by

Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases.
Li Z, Wahl MI, Eguinoa A, Stephens LR, Hawkins PT, Witte ON. Li Z, et al. Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13820-5. doi: 10.1073/pnas.94.25.13820. Proc Natl Acad Sci U S A. 1997. PMID: 9391111 Free PMC article.
Ethanol-Induced Changes in PKCε: From Cell to Behavior.
Pakri Mohamed RM, Mokhtar MH, Yap E, Hanim A, Abdul Wahab N, Jaffar FHF, Kumar J. Pakri Mohamed RM, et al. Front Neurosci. 2018 Apr 12;12:244. doi: 10.3389/fnins.2018.00244. eCollection 2018. Front Neurosci. 2018. PMID: 29706864 Free PMC article. Review.
Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2.
Arnould T, Sellin L, Benzing T, Tsiokas L, Cohen HT, Kim E, Walz G. Arnould T, et al. Mol Cell Biol. 1999 May;19(5):3423-34. doi: 10.1128/MCB.19.5.3423. Mol Cell Biol. 1999. PMID: 10207066 Free PMC article.
Reverse phase protein arrays enable glioblastoma molecular subtyping.
Hutter G, Sailer M, Azad TD, von Bueren AO, Nollau P, Frank S, Tostado C, Sarvepalli D, Ghosh A, Ritz MF, Boulay JL, Mariani L. Hutter G, et al. J Neurooncol. 2017 Feb;131(3):437-448. doi: 10.1007/s11060-016-2316-5. Epub 2016 Nov 17. J Neurooncol. 2017. PMID: 27858266
Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting.
Bhattacharya R, Kwon J, Li X, Wang E, Patra S, Bida JP, Bajzer Z, Claesson-Welsh L, Mukhopadhyay D. Bhattacharya R, et al. J Cell Sci. 2009 Apr 1;122(Pt 7):1025-34. doi: 10.1242/jcs.041913. J Cell Sci. 2009. PMID: 19295129 Free PMC article.

References

1. J Biol Chem. 1994 Nov 11;269(45):27823-6 - PubMed
1. Bioessays. 1994 Aug;16(8):565-76 - PubMed
1. Cell. 1995 Jan 27;80(2):269-78 - PubMed
1. FASEB J. 1995 Apr;9(7):484-96 - PubMed
1. Cell. 1988 Jun 3;53(5):731-41 - PubMed

Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase - PubMed (original) (raw)